Portal-systemic encephalopathy in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt treatment of acutely bleeding esophageal varices in cirrhosis

Annals of Surgery

Volumn 250, Issue 4, 2009, Pages 598-609

  Orloff, Marshall J ^a   Isenberg, Jon I ^a   Wheeler, Henry O ^a   Haynes, Kevin S ^a   Jinich Brook, Horacio ^a   Rapier, Roderick ^a   Vaida, Florin ^a   Hye, Robert J ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMMONIA;

ALCOHOL ABSTINENCE; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIET RESTRICTION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEAR; FLAPPING TREMOR; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MENTAL HEALTH; PATIENT COUNSELING; PORTOCAVAL SHUNT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL TIME; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; EMERGENCY TREATMENT; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTACAVAL SHUNT, SURGICAL; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SCLEROTHERAPY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70349667201     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b73126     Document Type: Article

References (38)

1. Garcia N Jr, Sanyal AJ. Portal hypertension. Clin Liver Dis. 2001;5:1-26.
2. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol. 1997;92:1081-1091.
3. Khan S, Tudur Smith C, Williamson P, et al. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Co-chrane Database Syst Rev. 2006:CD000553.
4. McDermott WV, Barnes BA, Nardi GL, et al. Postshunt encephalopathy. Surg Gynecol Obstet. 1968;126:585-590.
5. Voorhes AB, Price JB, Britton RC. Portasystemic shunting procedures for portal hypertension. Am J Surg. 1970;119:501-505.
6. Panke WF, Rousselot LM, Burchell AR. A sixteen-year experience with end-to-side portacaval shunt for variceal hemorrhage: analysis of data and comparison with other types of portasystemic anastomoses. Ann Surg. 1968; 168:957-965.
7. Mutchnick MG, Lerner E, Conn HO. Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenter-ology. 1974;66:1005-1019.
8. Bismuth H, Franco D, Hepp J. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg. 1974; 179:209-218.
9. Malt RA, Szczerban J, Malt RB. Risks in therapeutic portacaval and spleno-renal shunts. Ann Surg. 1976;184:279-289.
10. Grace ND, Conn HO, Resnick RH, et al. Distal splenorenal versus portal systemic shunts after haemorrhage from varices: a randomized controlled trial. Hepatology. 1988;8:1475-1481.
11. Rikkers LF. The changing spectrum of treatment for variceal bleeding. Ann Surg. 1998;228:536-546.
12. Spina GP, Henderson JM, Rikkers LF, et al. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal bleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol. 1992;16:338-345.
13. Harley HA, Morgan T, Redeker AG, et al. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology. 1986;91:802-809.
14. Orloff MJ, Isenberg JI, Wheeler HO, et al. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg. 2009;209:25-45.
15. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987-1991. (Pubitemid 32366951)
16. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-694. (Pubitemid 32322245)
17. Orloff MJ, Orloff SL, Orloff MS. Portacaval shunts: side-to-side and end-to-side. In: Clavien PA, Saar MG, Fong Y, eds. Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery. Heidelberg, Berlin: Springer-Verlag; 2007:687-702.
18. Conn HO, Liberthal MM. The Hepatic Coma Syndromes and Lactulose. Baltimore, MD: Williams & Wilkins; 1978.
19. Bell RH Jr, Hyde PV, Skivolocki WP, et al. Prospective study of portasys-temic encephalopathy after emergency portacaval shunt for bleeding varices. Am J Surg. 1981;142:144-150.
20. Korula J, Yelin A, Yamada S, et al. A prospective randomized controlled comparison of chronic endoscopic variceal sclerotherapy and portal-systemic shunt for variceal hemorrhage in Child?s class A cirrhotics: a preliminary report. Gastroenterology. 1987;92:1745.
21. Planas R, Boix J, Broggi M, et al. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenter-ology. 1991;100:1078-1086.
22. Isaksson B, Jeppsson B, Gengtsson F, et al. Mesocaval shunt or repeated sclerotherapy: effects on rebleeding and encephalopathy-a randomized trial. Surgery. 1995;117:498-504.
23. Henderson JM, Kutner MH, Millikan WJ, et al. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective randomized trial. Ann Intern Med. 1990;112:262-269.
24. Rikkers LF, Burnett DA, Volentine GD, et al. Shunt surgery versus endo-scopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg. 1987;206:261-271.
25. Rikkers LF, Jin G, Burnett DA, et al. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg. 1993;165:27-32.
26. Terés J, Bordas JM, Bravo D, et al. Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology. 1987;7:430-436.
27. Spina GP, Santambrogrio R, Opocher E, et al. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial. Ann Surg. 1990;211:178-186.
28. Langer B, Taylor BR, MacKenzie DR, et al. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side porta-caval shunt. Gastroenterology. 1985;88:424-429.
29. Terpstra OT, Ausema B, Bruining HA, et al. Late results of mesocaval interposition shunting for bleeding oesophageal varices. Br J Surg. 1987;74: 787-1780
30. Smith RB, Warren WD, Salam AA, et al. Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates. Ann Surg. 1980;192: 9-17.
31. Fletcher MS, Dawson JL, Williams R. Long-term follow-up of interposition mesocaval shunting in portal hypertension. Br J Surg. 1981;68:485-487.
32. Helton WS, Belshaw A, Althaus S, et al. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg. 1993;165:566-571.
33. LaBerge JM. Transjugular intrahepatic portosystemic shunt-role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax. Clin Liver Dis. 2006;10:583-598.
34. Bayer TD, Haskal ZJ. The role of transjugular intrahepatic shunt in the management of portal hypertension. Hepatology. 2005;41:386-400.
35. Sanyal AJ, Freedman AM, Shiftman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 1994;20:46-55.
36. Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosys-temic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994; 330:165-171.
37. Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 1995;23:123-128.
38. Orloff MJ, Orloff MS, Orloff SL, et al. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg. 1995;180: 257-272.